Mitochondrial-targeting fluorescent small molecule IR-780 alleviates radiation-induced brain injury
Brain Research · 2023
DOI: 10.1016/j.brainres.2023.148285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2023. Verfasst von Can Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Army Medical University, 400038 Chongqing, China. Hauptthemen laut MEDLINE: Endothelial Cells, Brain Injuries. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Radiation-induced brain injury (RIBI) is a common complication of radiation therapy for brain tumors. Vascular damage is one of the key factors closely related to the severity of the RIBI. However, effective vascular target treatment strategies are lacking. Previously, we have identified a fluorescent small molecule dye, IR-780, which shows the properties of injury tissue targeting and provided protection against various injuries by modulating oxidative stress. This study aims to validate the therapeutic effect of IR-780 on RIBI. The effectiveness of IR-780 against RIBI has been comprehensively evaluated through techniques such as behavior, immunofluorescence staining, quantitative real-time polymerase chain reaction, Evans Blue leakage experiments, electron microscopy, and flow cytometry. Results show that IR-780 improves cognitive dysfunction, reduces neuroinflammation, restores the expression of tight junction proteins in the blood-brain barrier (BBB), and promotes the recovery of BBB function after whole brain irradiation. IR-780 also accumulates in injured cerebral microvascular endothelial cells, and its subcellular location is in the mitochondria. More importantly, IR-780 can reduce the levels of cellular reactive oxygen species and apoptosis. Moreover, IR-780 has no significant toxic side effects. IR-780 alleviates RIBI by protecting vascular endothelial cells from oxidative stress, reducing neuroinflammation, and restoring BBB function, suggesting IR-780 as a promising treatment candidate for RIBI therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Army Medical University, 400038 Chongqing, China.
- Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Army Medical University, 400038 Chongqing, China; Department of Oncology, The Affiliated Hospital of Southwest Medical Unive…
- Department of Military Cognitive Psychology, School of Psychology, Army Medical University, 400038 Chongqing, China.
- Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Army Medical University, 400038 Chongqing, China. Electronic address: czlwx1811@163.com.
- Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Army Medical University, 400038 Chongqing, China. Electronic address: shicm@sina.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, C., Zheng, J., Chen, W., Yang, W., Tan, X., Fan, X., Shen, G., Qu, L., Chen, Z., & Shi, C. (2023). Mitochondrial-targeting fluorescent small molecule IR-780 alleviates radiation-induced brain injury. Brain Research. https://doi.org/10.1016/j.brainres.2023.148285
Vancouver
Zhang C, Zheng J, Chen W, Yang W, Tan X, Fan X, et al. Mitochondrial-targeting fluorescent small molecule IR-780 alleviates radiation-induced brain injury. Brain Research. 2023. doi:10.1016/j.brainres.2023.148285
BibTeX
@article{Zhang2023,
author = {Zhang, Can and Zheng, Jiancheng and Chen, Wanchao and Yang, Wei and Tan, Xu and Fan, Xiaotang and Shen, Gufang and Qu, Langfan and Chen, Zelin and Shi, Chunmeng},
title = {Mitochondrial-targeting fluorescent small molecule IR-780 alleviates radiation-induced brain injury},
journal = {Brain Research},
year = {2023},
doi = {10.1016/j.brainres.2023.148285}
}
EUVIMED